Robeco Institutional Asset Management B.V. Lowers Position in DocuSign, Inc. (NASDAQ:DOCU)

Robeco Institutional Asset Management B.V. decreased its holdings in shares of DocuSign, Inc. (NASDAQ:DOCU) by 40.8% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 768,177 shares of the company’s stock after selling 528,340 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in DocuSign were worth $69,090,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Modus Advisors LLC purchased a new stake in DocuSign during the fourth quarter worth $36,000. Itau Unibanco Holding S.A. bought a new stake in shares of DocuSign in the 3rd quarter valued at about $28,000. Brooklyn Investment Group purchased a new position in shares of DocuSign in the 3rd quarter worth approximately $33,000. Avior Wealth Management LLC raised its stake in shares of DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after acquiring an additional 145 shares in the last quarter. Finally, Friedenthal Financial purchased a new stake in DocuSign during the fourth quarter valued at approximately $54,000. Institutional investors own 77.64% of the company’s stock.

Insider Buying and Selling at DocuSign

In other DocuSign news, Director Teresa Briggs sold 534 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total value of $50,516.40. Following the sale, the director now owns 7,736 shares in the company, valued at approximately $731,825.60. This represents a 6.46 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Allan C. Thygesen sold 7,764 shares of the firm’s stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $69.95, for a total transaction of $543,091.80. Following the sale, the chief executive officer now directly owns 107,825 shares in the company, valued at $7,542,358.75. The trade was a 6.72 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 693,537 shares of company stock valued at $66,575,817. 1.66% of the stock is owned by insiders.

DocuSign Price Performance

NASDAQ:DOCU opened at $95.46 on Thursday. The company’s fifty day moving average price is $90.40 and its 200-day moving average price is $72.25. DocuSign, Inc. has a 1-year low of $48.70 and a 1-year high of $107.86. The firm has a market capitalization of $19.28 billion, a P/E ratio of 19.68, a PEG ratio of 8.30 and a beta of 0.88.

Analyst Ratings Changes

DOCU has been the topic of several analyst reports. Jefferies Financial Group lifted their price target on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Morgan Stanley upped their target price on DocuSign from $62.00 to $97.00 and gave the company an “equal weight” rating in a research report on Friday, December 6th. Citigroup raised their price target on DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a report on Friday, December 6th. JMP Securities restated a “market outperform” rating and set a $124.00 price objective on shares of DocuSign in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. lifted their target price on shares of DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research note on Tuesday, December 3rd. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, DocuSign has a consensus rating of “Hold” and an average price target of $92.45.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.